Robert Johnson remains in remission more than three years after participating in a pioneering immunotherapy clinical trial for his stage IV adenocarcinoma non-small cell lung cancer.
Non-small cell lung cancer
Lung cancer is divided into two general categories based on its appearance under the microscope: small cell and non-small cell. Non-small cell is the more common type and currently accounts for about 87 percent of lung cancers. Doctors make a distinction between the two types of lung cancers because treatment approaches differ for each. Symptoms … Continued
We all know what to expect following a car accident: insurance claims, whiplash, maybe even a broken bone. Cancer, though? Not so common. For 40-year-old Laura Greco, this is what happened following a collision on a snowy day in February 2015. If I hadn’t been in the car accident, I wouldn’t have found the cancer … Continued
The FDA announced today it has approved a new pill to treat certain patients with advanced non-small cell lung cancer (NSCLC). The oral medication, Tagrisso (osimetinib), has been approved for NSCLC patients whose tumors have a specific epidermal growth factor receptor (EGFR) mutation (T790M) and whose disease has worsened after treatment with other EGFR-blocking therapy. … Continued